Martin H Voss Selected Research

Martin H Voss Research Topics

Disease

67	Renal Cell Carcinoma (Grawitz Tumor) 12/2023 - 08/2011
58	Neoplasms (Cancer) 11/2023 - 05/2013
9	Kidney Neoplasms (Kidney Cancer) 04/2024 - 04/2014
8	Disease Progression 11/2023 - 07/2017
4	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 07/2013 - 01/2011
3	Hypoxia (Hypoxemia) 10/2023 - 07/2013
3	Neoplasm Metastasis (Metastasis) 12/2018 - 04/2014
2	Anemia 01/2022 - 08/2017
2	Diarrhea 01/2022 - 07/2017
2	Fatigue 01/2022 - 07/2017
2	Pneumonia (Pneumonitis) 01/2021 - 03/2017
2	Leiomyomatosis 01/2021 - 05/2014
2	Hepatocellular Carcinoma (Hepatoma) 01/2019 - 01/2019
2	Lung Neoplasms (Lung Cancer) 01/2019 - 01/2018
2	Carcinoma (Carcinomatosis) 01/2016 - 05/2015
1	Medullary Carcinoma 11/2023
1	Genomic Instability 11/2023
1	Inflammation (Inflammations) 10/2022
1	Human Influenza (Influenza) 01/2022
1	Microsatellite Instability 10/2021
1	Endometrial Neoplasms (Endometrial Cancer) 11/2020
1	Urinary Bladder Neoplasms (Bladder Cancer) 11/2020
1	Overweight 01/2020
1	Carcinogenesis 01/2019
1	Adenocarcinoma 01/2019
1	Turcot syndrome 01/2019

Drug/Important Bio-Agent (IBA)

27	Immune Checkpoint InhibitorsIBA 12/2023 - 10/2016
12	Biomarkers (Surrogate Marker)IBA 12/2022 - 03/2016
11	NivolumabIBA 01/2023 - 10/2016
11	Everolimus FDA Link 01/2022 - 04/2012
10	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2023 - 04/2012
9	DNA (Deoxyribonucleic Acid)IBA 10/2023 - 04/2014
8	Sunitinib (Sutent)FDA Link 01/2022 - 04/2012
7	Tyrosine Kinase InhibitorsIBA 10/2023 - 07/2017
5	TOR Serine-Threonine KinasesIBA 01/2019 - 04/2012
4	pembrolizumabIBA 10/2023 - 01/2020
4	IpilimumabIBA 01/2023 - 12/2017
4	Axitinib (AG 013736)IBA 01/2022 - 07/2017
4	Mechanistic Target of Rapamycin Complex 1IBA 01/2021 - 01/2016
4	Bevacizumab (Avastin)FDA Link 12/2020 - 02/2016
4	PlatinumIBA 12/2017 - 07/2013
3	Fumarate Hydratase (Fumarase)IBA 11/2023 - 05/2014
3	avelumabIBA 11/2023 - 01/2020
3	lenvatinibIBA 10/2023 - 01/2021
3	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2023 - 01/2016
3	cabozantinibIBA 01/2023 - 01/2022
3	pazopanib FDA Link 10/2021 - 10/2018
3	MTOR InhibitorsIBA 10/2018 - 08/2011
3	Paclitaxel (Taxol)FDA LinkGeneric 12/2017 - 01/2011
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 11/2023 - 08/2017
2	Glutamine (L-Glutamine)FDA Link 01/2022 - 01/2021
2	GlutaminaseIBA 01/2022 - 01/2021
2	RNA (Ribonucleic Acid)IBA 10/2021 - 10/2016
2	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021 - 10/2016
2	Monoclonal AntibodiesIBA 07/2020 - 03/2017
2	NucleotidesIBA 01/2019 - 02/2016
2	Proteins (Proteins, Gene)FDA Link 01/2019 - 05/2014
2	human ALK1-Fc fusion proteinIBA 01/2019 - 07/2017
2	NVP-BKM120IBA 12/2017 - 04/2015
2	taxaneIBA 12/2017 - 04/2015
2	Carboplatin (JM8)FDA LinkGeneric 12/2017 - 04/2015
2	Messenger RNA (mRNA)IBA 01/2017 - 11/2016
2	AntigensIBA 11/2016 - 01/2016
2	Cisplatin (Platino)FDA LinkGeneric 01/2016 - 01/2011
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 07/2013 - 04/2012
1	Succinate Dehydrogenase (Fumarate Reductase)IBA 11/2023
1	talazoparibIBA 11/2023
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 11/2023
1	belzutifanIBA 10/2023
1	atezolizumabIBA 01/2023
1	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 10/2022
1	Transaminases (Aminotransferases)IBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Cell-Free Nucleic AcidsIBA 01/2022
1	Circulating Tumor DNAIBA 01/2022
1	durvalumabIBA 01/2022
1	Small Cytoplasmic RNAIBA 10/2021
1	SteroidsIBA 01/2021
1	Dasatinib (BMS 354825)FDA Link 11/2020
1	sapanisertibIBA 11/2020
1	Phosphotransferases (Kinase)IBA 11/2020
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 11/2020
1	TensinsIBA 01/2019
1	emibetuzumabIBA 01/2019
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2019
1	RamucirumabIBA 01/2019
1	Checkpoint Kinase 2IBA 01/2019
1	CH5183284IBA 01/2019
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2019
1	Proto-Oncogene Proteins c-metIBA 01/2019
1	Activin Receptors (Activin Receptor)IBA 01/2019
1	Neurofibromin 2 (Merlin)IBA 01/2019
1	Formaldehyde (Formol)FDA Link 12/2018
1	ParaffinIBA 12/2018

Therapy/Procedure

43	Therapeutics 12/2023 - 02/2013
22	Immunotherapy 04/2024 - 01/2016
12	Nephrectomy 12/2023 - 01/2017
6	Drug Therapy (Chemotherapy) 11/2023 - 06/2011
2	Salvage Therapy 02/2016 - 01/2011
1	Precision Medicine 12/2018